| |
| |
|
| Insider
Information: |
Herrmann John A Iii |
| Relationship: |
EVP, Chief Legal Officer |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
13,233 |
|
|
Indirect Shares
|
3,384 |
|
|
| Direct
Value |
$4,757 |
|
|
|
Indirect Value
|
$1,217 |
|
|
| Total
Shares |
16,617 |
|
|
| Total
Value |
$5,974 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novavax Inc |
NVAX |
EVP, Chief Legal Officer |
2023-12-14 |
13,233 |
2023-06-25 |
3,384 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
77 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
SVP, General CounselOfficer |
• – – |
2014-06-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,664 |
|
- |
|
| NVAX |
Novavax Inc |
SVP, General Counsel |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$20,406 |
D/D |
8,950 |
16,614 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, General Counsel |
• – – |
2015-01-31 |
4 |
B |
$2.28 |
$22,501 |
D/D |
9,869 |
26,483 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, General Counsel |
• – – |
2015-07-31 |
4 |
B |
$2.28 |
$3,425 |
D/D |
1,502 |
27,985 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
SVP, General Counsel |
• – – |
2015-12-16 |
4 |
S |
$8.64 |
$241,420 |
D/D |
(27,945) |
40 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, General Counsel |
• – – |
2016-01-31 |
4 |
B |
$4.38 |
$9,075 |
D/D |
2,072 |
2,112 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, General Counsel |
• – – |
2017-01-31 |
4 |
B |
$1.12 |
$5,555 |
D/D |
4,960 |
7,072 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, General Counsel |
• – – |
2019-09-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,933 |
5,286 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, General Counsel |
• – – |
2019-09-08 |
4 |
D |
$5.50 |
$9,037 |
D/D |
(1,643) |
3,643 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, General Counsel |
• – – |
2019-09-17 |
4 |
S |
$7.07 |
$25,757 |
D/D |
(3,643) |
0 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, General Counsel |
• – – |
2020-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
449 |
449 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, General Counsel |
• – – |
2020-03-08 |
4 |
D |
$12.48 |
$2,172 |
D/D |
(174) |
275 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, General Counsel |
• – – |
2020-05-18 |
4 |
OE |
$25.60 |
$339,448 |
D/D |
12,961 |
5,737 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, General Counsel |
• – – |
2020-05-18 |
4 |
S |
$49.44 |
$640,792 |
D/D |
(12,961) |
275 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Legal Officer |
• – – |
2020-08-18 |
4 |
OE |
$27.00 |
$2,488,613 |
D/D |
46,242 |
46,517 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Legal Officer |
• – – |
2020-08-18 |
4 |
S |
$143.92 |
$6,673,982 |
D/D |
(46,242) |
275 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Legal Officer |
• – – |
2020-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,873 |
20,223 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Legal Officer |
• – – |
2020-09-26 |
4 |
D |
$113.56 |
$1,912,805 |
D/D |
(16,844) |
18,304 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Legal Officer |
• – – |
2020-09-28 |
4 |
AS |
$107.22 |
$2,729,879 |
D/D |
(24,750) |
18,304 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Legal Officer |
• – – |
2020-09-28 |
4 |
OE |
$5.95 |
$147,263 |
D/D |
24,750 |
43,054 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Legal Officer |
• – – |
2020-09-29 |
4 |
AS |
$106.18 |
$1,934,667 |
D/D |
(18,029) |
275 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Legal Officer |
• – – |
2021-02-01 |
4 |
OE |
$5.95 |
$272,724 |
D/D |
15,022 |
15,297 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Legal Officer |
• – – |
2021-02-01 |
4 |
AS |
$239.04 |
$3,627,789 |
D/D |
(15,022) |
275 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Legal Officer |
• – – |
2021-02-26 |
4 |
AS |
$219.55 |
$652,759 |
D/D |
(2,895) |
275 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Legal Officer |
• – – |
2021-02-26 |
4 |
OE |
$5.95 |
$42,892 |
D/D |
2,895 |
3,170 |
0 |
- |
|
77 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
